RTM Management Consultants, LLC draws upon deep biopharmaceutical industry experience to serve Government and Government-focused clients. PRTM uses best-in-class industry models paired with government-proven frameworks to bring new countermeasures from early technology development to commercial-scale production. PRTM's teams deliver objective, apolitical strategies to your toughest biodefense problems. We help you understand best-in-class practices from both the commercial and government sectors. During all of our client engagements, PRTM works to deliver strategic value that lasts long after our consultants have departed.

Baxter International Inc. is a global health-care company that, through its subsidiaries, assists health-care professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. Baxter Vaccines, a business unit of the Baxter BioScience division, is involved in researching, developing and manufacturing vaccines against infectious disease and for biosecurity. With approximately 51,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

IR BioSciences Holdings, Inc. is a development-stage biopharmaceutical company. Through our subsidiary ImmuneRegen BioSciences, Inc., we are engaged in the research and development of therapeutics to be used for the protection of the body from exposure to biological agents, including influenza and anthrax, as well as other harmful agents such as toxic chemicals and radiation. The company's management team and diverse advisory boards gives it the expertise, both legislatively and scientifically, to develop and make available novel and effective countermeasures and CBRN protectants.

McKenna Long & Aldridge LLP is a leader in the growing field of public health care and Biodefense procurement. We provide legal advice, government affairs counseling and venture capital consulting to pharmaceutical and biotech companies interested in securing contracts from the National Institutes of Health, Centers for Disease Control, Office of Health and Safety, Department of Defense and the Department of Health and Human Services. With approximately 350 lawyers and public policy advisors, we provide business solutions in the areas of corporate law, government contracts, intellectual property and technology, complex litigation, public policy and regulatory affairs, international law, real estate and finance. To learn more, log on to www.mckennalong.com.

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 2,300 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at www.medimmune.com.

PharmaJet has developed an FDA-cleared class II medical device for delivery of needle free injections of liquid medicines or vaccines, subcutaneously or intramuscularly. Cost competitive with glass vial packaging and a needle syringe, PharmaJet’s needle-free jet injection technology comprises of a separate injector and cocking device, which provides spring-force delivery of liquid medicine or vaccine to a patient, using a proprietary, disposable vial, which can be used in sophisticated health care environments, mass vaccination programs, and animal health.

SM&A (NASDAQ: WINS) is the world’s foremost management consulting firm providing leadership and mentoring solutions to PLAN for business capture, WIN competitive procurements and profitably PERFORM on the projects and programs won. Over 25 years, SM&A has supported 1,000+ procurements worth more than $340 billion with an 85% WinRate. Post-award, SM&A has support 150+ programs worth more than $1 trillion with solutions to increase program profitability and improve program performance.

Founded in 1961, the Academy for Educational Development is an independent, nonprofit organization committed to solving critical social problems and building the capacity of individuals, communities, and institutions to become more self-sufficient. AED works in all the major areas of human development, with a focus on improving education, health, and economic opportunities for the least advantaged in the United States and developing countries throughout the world.